On the other hand, it was seen that miR-411 inhibited the progression of cervical cancer when interacting directly with STAT3; the authors also indicated that this miRNA may represent a new potential therapeutic target and prognostic marker for patients with this disease [50]. This evidence concerns the gene STAT3 and cervical carcinoma.